FY 2009 HOUSE APPROPRIATIONS COMMITTEE PUBLIC TESTIMONY  April 2, 2008
The Endocrine Society would like to submit the following testimony regarding Fiscal Year 2009 federal appropriations for biomedical research, with emphasis on appropriations for the National Institutes of Health. The Endocrine Society is the world's largest and most active professional organization of endocrinologists representing over 14,000 members worldwide. Our organization is dedicated to promoting excellence in research, education, and clinical practice in the field of endocrinology. The Society is comprised of thousands of researchers who depend on federal support for their careers and their scientific advances.
| Biomedical Research Funding UPDATED March 19, 2008
A half century of sustained investment by the United States Federal Government in biomedical research has dramatically advanced the health and improved the lives of the American people. The National Institutes of Health (NIH) specifically has had a significant impact on the United State's global preeminence in research and fostered the development of a biomedical research enterprise that is unrivaled throughout the world. As the world's largest supporter of biomedical research, the NIH competitively awards extramural grants and supports in-house research. However, with the continued decline in real dollars allocated to biomedical research each year by the federal government, the opportunities to discover life-changing cures and treatments will drastically decrease.
| Senate DXA Dear Colleague Letter March 4, 2008
Co-sponsor the Medicare Fracture Prevention and Osteoporosis Testing Act, by Ken Salazar and Olympia Snowe
| Testimony of Dr. Alan D. Rogol on HGH, presented to the House Government Reform Committee February 19, 2008
One of the remarkable roles of the endocrine system is the regulation of growth and
development throughout our bodies. This work is directed by the pituitary gland — perhaps
the most important “master gland” of the endocrine system. A small oval-shaped organ at
the base of the brain, the pituitary gland releases a variety of hormones into the blood
stream. One of these is growth hormone called somatotropin. Once in the blood, growth
hormone travels to bone, muscle, and other tissues where it has many effects. |
|
Past Legislative/Regulatory Action
NIH Public Access Policy - Akaka November 12, 2007
We the undersigned publisher members of the Professional and Scholarly Publishing Division of
the Association of American Publishers (www.publishers.org), and members of a coalition of
academic and society publishers from within the DC Principles Coalition of scientific publishers
(www.dcprinciples.org) are writing to express strong opposition with language in the Fiscal Year
2008 Labor, Health and Human Services, Education, and Related Agencies (LHHS)
Appropriations Bill that would transform the public access policy of the National Institutes of
Health (NIH) from a voluntary initiative into a mandatory federal policy.
| PQRI 2008 Measure Sign-On October 31, 2007
The undersigned organizations are writing to urge CMS to provide the utmost flexibility for the inclusion of physician quality measures in the 2008 Physician Quality Reporting Initiative (PQRI). We are concerned that CMS regulatory and administrative deadlines have the potential to delay implementation of a number of important measures developed in 2007. As a result many physicians will not have an opportunity to participate in the PQRI until 2009.
| SGR Norwalk Sign-on May 21, 2007
The undersigned national organizations representing physicians and other health professionals are writing to urge the Centers for Medicare and Medicaid Services (CMS) to adopt policy changes for the 2008 Medicare payment schedule that will help avert payment cuts driven by the Sustainable Growth Rate (SGR) formula and lessen the score for Congressional proposals to address the SGR.
| FY 08 Increase - Byrd May 21, 2007
The undersigned education, training, disability, public health, medical research, child welfare organizations and labor unions representing the full range of stakeholders in the programs of the Departments of Education, Health and Human Services and Labor, urge you to ensure that the final FY 2008 302b allocation for the House and Senate Labor, Health and Human Services, Education Appropriations Subcommittees reflects at least a $14 billion increase above the FY 2007 level for these critically important programs.
| FY 08 Increase - Obey May 21, 2007
The undersigned education, training, disability, public health, medical research, child welfare organizations and labor unions representing the full range of stakeholders in the programs of the Departments of Education, Health and Human Services and Labor, urge you to ensure that the final FY 2008 302b allocation for the House and Senate Labor, Health and Human Services, Education Appropriations Subcommittees reflects at least a $14 billion increase above the FY 2007 level for these critically important programs.
| SGR Legislative Options Sign-on May 18, 2007
Outline for 2007 Medicare SGR Legislation
Recommendation 1: The SGR should be repealed and replaced with an update system that
reflects increases in physicians’ and other health professionals’ practice costs.
|
FY 2009 HOUSE APPROPRIATIONS COMMITTEE PUBLIC TESTIMONY April 2, 2008
The Endocrine Society would like to submit the following testimony regarding Fiscal Year 2009 federal appropriations for biomedical research, with emphasis on appropriations for the National Institutes of Health. The Endocrine Society is the world's largest and most active professional organization of endocrinologists representing over 14,000 members worldwide. Our organization is dedicated to promoting excellence in research, education, and clinical practice in the field of endocrinology. The Society is comprised of thousands of researchers who depend on federal support for their careers and their scientific advances.
| Testimony of Dr. Alan D. Rogol on HGH, presented to the House Government Reform Committee February 19, 2008
One of the remarkable roles of the endocrine system is the regulation of growth and development throughout our bodies. This work is directed by the pituitary gland — perhaps the most important “master gland” of the endocrine system. A small oval-shaped organ at the base of the brain, the pituitary gland releases a variety of hormones into the blood stream. One of these is growth hormone called somatotropin. Once in the blood, growth hormone travels to bone, muscle, and other tissues where it has many effects.
| Public Testimony Submitted By The Endocrine Society On Rosiglitazone August 1, 2007
On May 21, 2007, the New England Journal of Medicine released a meta-analysis by Steven Nissen, M.D., and Kathy Wolski, M.P.H., examining the effects of rosiglitazone (Avandia) on cardiovascular morbidity and mortality. Since it was approved in 1999, rosiglitazone has been used by almost 6 million patients in the US for the treatment of type 2 diabetes. The findings of the NEJM article are based on 42 studies that met the inclusion criteria: duration of more than 24 weeks; use of a randomized control group not receiving rosiglitazone; and availability of outcome data for myocardial infarction and death from cardiovascular causes. |
|
|
